Articles On Imugene (ASX:IMU)

Aussie small cap index falls 1.4% The ASX200 down 1.65% Thursday is Arafura Day!   Down less than 2% and I think we can call that a win. No one likes the sight of blood and after the major Wall Street indices shed more than 3.5% a piece,...

The Imugene Limited (ASX: IMU) share price took off today despite the company’s silence. However, today’s gains might have been a belated reaction to the news the company announced to the ASX yesterday. As of Thursday’s close, the Imugene...

Blue-chip retailers suffered bruising losses after a corporate profit scare pushed the ASX sharply lower. Bunnings owner Wesfarmers, Woolworths and Coles spearheaded falls as the S&P/ASX 200 slumped 118 points or 1.65 per cent. Th...

Markets may be tanking but there are two ASX shares on the All Ordinaries Index (ASX: XAO) that are shooting the lights out on Thursday. The two have surged by more than 10% each – an impressive gain on any day. But it’s particularly notab...

ShareCafeLunch Report: 19 May, 2022 by Melissa Darmawan   Consumer staples and discretionary stocks are leading the dive on the Australian sharemarket, shrugging off the improved labour market and giving back three days of gains. Bunnings a...

The share market gave up almost three days of gains after renewed inflation worries triggered Wall Street’s worst sell-off since 2020. The S&P/ASX 200 tumbled 102 points or 1.42 per cent by mid-session. Ten of 11 sectors declined....

At lunch on Thursday, the S&P/ASX 200 Index (ASX: XJO) has followed the lead of Wall Street and is tumbling notably lower. The benchmark index is currently down 1.55% to 7,072 points. Here’s what is happening on the ASX 200 today: Aris...

Highlights: The benchmark index ASX200 was down 1.75% in opening trade on Thursday Overnight selloff on Wall Street spooked investors and impacted risk sentiments All the 11 sectors on the ASX are in the red today Australian equit...

Imugene (IMU) doses its first patient in a phase one clinical trial to shrink advanced tumours The company, in collaboration with City of Hope, dosed the first patient in a trial evaluating the safety of the novel cancer-killing virus, whi...

ASX is set to open higher after a Wall Street rally US Fed chairman Jerome Powell says the Fed will keep pushing until inflation declines Crucial Aussie unemployment data due out tomorrow Aussie shares are set to open higher this morning...

ShareCafeEvening Report: 16 May, 2022 by Lauren Evans   Australian shares struggled to maintain their early morning rally after China revealed that it had suffered an 11.1 per cent drop in retail sales during April, which was worse than exp...

Highlights ASX 200 closed up, gaining 17.90 points or 0.25% to 7,093.00. China’s decision to lock down major cities amid worries about Covid-19 resurgence could strain supply chains; Russia’s invasion of Ukraine continues to raise ener...

Blue chips pare gains after downbeat Chinese economic data Industrial sector jumps after speculation about a takeover attempt of Brambles Bitcoin and the crypto market have stabilised   Asian markets reacted negatively to China’s latest e...

The S&P/ASX 200 Index (ASX: XJO) is having a reasonably positive start to the week. In afternoon trade, the benchmark index is up 0.35% to 7,100 points. Four ASX shares that have failed to follow the market higher today are listed belo...

ShareCafeLunch Report: 16 May, 2022 by Lauren Evans   The Aussie sharemarket has advanced this morning buoyed by a jump in Brambles (ASX:BXB) and tech shares. This comes after an optimistic finish on Wall Street, which saw a relief-rally fo...

At lunch on Monday, the S&P/ASX 200 Index (ASX: XJO) has started the week on a reasonably positive note. The benchmark index is currently up 0.3% to 7,096.5 points. Here’s what is happening on the ASX 200 today: Goodman Q3 update impre...

A relief rally lifted the ASX 200 back above the 7000 level as a pause in this week’s bloodletting on Wall Street brought buyers back to market. The S&P/ASX 200 bounced 95 points or 1.36 per cent to 7036 by mid-session. The rally bro...

The share market slumped to a 15-week low before partially recovering as rising US futures sharpened hopes of a relief rally tonight. The S&P/ASX 200 finished 69.5 points or 0.98 per cent in the red at 7051 after trading as low as 69...

Fears of a global slowdown helped drive the share market to its lowest since January before a partial mid-morning recovery.   The S&P/ASX 200 dropped more than 2.5 per cent in early action before buyers stepped in. By mid-session the...

Emyria announced progress on its MDMA (ecstasy) program Imugene gets green light for a Phase 2 Australian clinical trial Beamtree wins US$7m deal   Emyria Limited (ASX: EMD) has announced positive progress on its MDMA (also known as ‘ecst...

Immuno-oncology company Imugene (ASX:IMU) has announced it has received Human Research Ethics Committee approval to commence a Phase 2 clinical trial of its immunotherapy candidate, HER-Vaxx in Australia.

ASX to open extend losses as Wall Street crashes again Oil prices plunge 9% as EU ban on Russian oil fails to gain approval Aussie dollar plunges below US70c   The ASX 200 is set to extend its losses for a third consecutive day, following...

Imugene (IMU) receives Human Research Ethics Committee (HREC) approval to start a phase two clinical trial of its cancer vaccine, HER-Vaxx in Australia This approval confirms the company has completed pre-clinical safety and efficacy for t...

Highlights ASX 200 finished today’s session down 1.2% or 84.90 points to 7.120, The index was dragged lower by real estate, technology, and materials sectors. Rate worries, continued supply-side pressures, and a tightening lockdown in...

Imugene has rejected suggestions it was slow to update the market after copping its second notice from the ASX about the cancellation of a deal.

ASX 200 extended loss, down by 1.43% All sectors fell except for Energy Tech and Real Estate were the worst performers   The ASX has extended its selloff as local stocks closed to the lowest level in two months. At the close, the benchmar...

The share market closed at a seven-week low as soft Chinese economic data pushed the dollar below 70 US cents and sapped buying interest in mining stocks. The S&P/ASX 200 shed 85 points or 1.18 per cent. Today’s close was the weakest...

In late trade, the S&P/ASX 200 Index (ASX: XJO) looks set to record a disappointing decline. At the time of writing, the benchmark index is down 1.4% to 7,102.9 points. Four ASX shares that are falling more than most are listed below....

Healthcare and life sciences expert Scott Power – a senior analyst with Morgans Financial for 24 years – on what the movers and shakers have been doing in health and which ASX health stocks make Scott’s Powerplays. Are you the cuddly type?...

Highlights ASX 200 edged 0.8% higher today, snapping a three-day losing streak and mirroring gains in US markets. In the US, Federal Reserve increased rates by 50 basis points, dashing worries that it might raise rates by 75 basis poin...

Some of the worst-performing corners of the market enjoyed a day in the sun after a relief rally on Wall Street inspired the ASX’s first advance this week. Gold miners, tech companies and small and micro caps outperformed as the S&P/...

Tech and commodity stocks steered the share market towards its first gain of the week following Wall Street’s best session since 2020. The S&P/ASX 200 overcame an early wobble to advance 44 points or 0.6 per cent by mid-session. T...

At lunch on Thursday, the S&P/ASX 200 Index (ASX: XJO) has followed the lead of US markets and is pushing higher. The benchmark index is currently up 0.65% to 7,352.5 points. Here’s what is happening on the ASX 200 today: NAB half-year...

At lunch on Wednesday, the S&P/ASX 200 Index (ASX: XJO) has given back the majority of its morning gains and is just a fraction higher. The benchmark index is currently trading at 7,316.8 points. Here’s what is happening on the ASX 200...

The Imugene Limited (ASX: IMU) share price is moving in circles during Tuesday afternoon following an update from the company. At the time of writing, the immuno-oncology company’s shares are down 1.58% to 18.7 cents. It’s worth noting tha...

Highlights ASX 200 dropped 1.2% to close 88 points lower at 7347 with all sectors lower.  Investors await Reserve Bank of Australia’s (RBA) monthly monetary policy decision meeting tomorrow. US Federal Reserve and Bank of England migh...

ASX 200 closed 1.27% lower in a Tech-led rout All 11 sectors were in the red ahead of the RBA meeting tomorrow Property prices in Sydney and Melbourne have dropped for the first time since Covid started in 2020   Tech stocks plunged and l...

Central Banks have their fingers on the fun button this week, and the markets are pricing in the big push. The Emerging Companies Index (XEC) has been sunk on day dot, down 2.3%. The S&P/ASX 200 index was down 1.2% at 4.15pm, with this...

Tech stocks slumped to an eight-week low as turmoil on Wall Street and caution ahead of a potential rate rise tomorrow fuelled a sharp share market retreat. The S&P/ASX 200 declined 88 points or 1.18 per cent. The tech sector shed al...

The Imugene Limited (ASX: IMU) share price is deep in the red today following a shock announcement from the company. At the time of writing, the immuno-oncology company’s shares are down 15% to 18.7 cents apiece. It’s worth noting that Imu...

Imugene (IMU) has scrapped its supply agreement with Merck & Co tradename MSD The parties joined forces in March to collaborate on a clinical trial assessing the safety and efficacy of IMU’s HER-Vaxx immunotherapy in combination with M...

The share market shed 100 points after Wall Street’s worst session since 2020 ensured the new month got off to a rocky start. Tech and property stocks spearheaded losses as the S&P/ASX 200 fell 101 points or 1.36 per cent by mid-sess...

A broad rally carried the share market towards a second day of gains at the end of a challenging month for investors. All 11 sectors rose as the S&P/ASX 200 put on 58 points or 0.79 per cent. The advance trimmed the index’s loss for...

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

ASX was down for third consecutive day Australia CPI was higher than expected at 5.1% Tech, consumer staples got smashed in a broad brushed selloff    ASX Tech stocks tumbled by over 2% today, as the possibility of a May rate hike gains m...

Prescient Thereapeutics gives hope with its personalised Car-T cell therapy Imugene working to activate the immune systems of cancer suffers to fight disease Rhythm Bioscience revolutionising the detection of bowel cancer According to th...

ASX 200 fell 1.5% and finished the week lower by  The Mining Index had its largest weekly drop since August Markets have been spooked after hawkish US Fed comments overnight   It was carnage across the board as local shares took a direct...

Highlights ASX200 closes trade about 0.56% higher at 7565.20 points today (19 April 2022). The Australian benchmark shrugged off global market weakness and overnight fall in the US market. Healthcare remained the top loosing sector on...

Local blue chips have gone into the Easter Break back in the green. The ASX 200 was up 44.4 points to 7,523.4 at close of trade. The ASX followed the lead of Wall Street overnight, which rallied and broke this week’s losing streak.All major...

Highlights ASX stocks trade in the green today (14 April 2022, 12 PM AEST) ahead of Easter festivities . Utilities remains the best performer amongst all the industrial sectors that are on a gaining spree. The ASX200 gained about 0...